Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Urofrance | JER : Journée Enseignement et Recherche du GETUG - Urofrance
Journée Enseignement et Recherche du GETUG (Groupe d’étude des tumeurs ...
JER GETUG 2024 - Partie 1 : Introduction et 30 ans du GETUG - YouTube
GetUg - Apps on Google Play
Pierre Blanchard: Early Toxicity Results from GETUG Adjuvant ...
6e édition de la journée Enseignement et Recherche du GETUG - YouTube
Formulaire d'inscription à la journée | Journée GETUG – Unicancer
Eligibility criteria of GETUG 14, GETUG 15, GETUG 16, and GETUG 17 ...
OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High ...
GETUG (@GETUG_Unicancer) / Posts / X
Quality assurance of contouring and dosimetric consistency in the GETUG ...
(PDF) PD-0046: Outcome according to pelvic radiotherapy in the GETUG 12 ...
High Risk Prostate - GETUG 18 - Conventional fractionation - Improved ...
Formulaire d'inscription | Journée GETUG – Unicancer
(PDF) OLIGOPELVIS - GETUG P07: A multicentre phase II trial of combined ...
présentation du GETUG - YouTube
(PDF) The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate ...
JER GETUG 2024 - Partie 2 : Cancers de la vessie et du rein - YouTube
Focus Meeting - Congrés d'Urologie à TOULOUSE
Getug, experts des cancers urologiques (prostate, testicule, vessie ...
ASCO GU 2024: Long-Term Results of Dose Escalation (80 vs 70 Gy ...
UroCCR: Réseau Français de Recherche sur le Cancer du Rein
#getug #tumeurs #urogénitales | Unicancer
#getug | Unicancer
ASTRO 2022: GETUG-AFU 22 Phase II Randomized Trial Evaluating Outcomes ...
Protocole GETUG/AFU 17
ESMO 2018: 12-Year Follow-Up of GETUG-12, A Phase 3 Trial of Docetaxel ...
ESMO 2018: Updated Results of GETUG-12, a Phase III Trial Of Docetaxel ...
CCMTV医学直播间
Radiotherapy for Prostate Cancer | PPT
ESOU 2019: Treatment of Positive Pelvic Lymph Nodes: Systemic Treatments
No Survival Benefit Reported With Docetaxel Added to Hormone Therapy in ...
Figure 1 from Patients' self-assessment versus investigators ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor ...
GETUG-AFU 15 | PPTX
#getug #getug #getug | Unicancer | 11 commentaires
#getug #getug | Unicancer
Salvage radiotherapy with or without short-term hormone therapy for ...
ASCO GU 2020: Randomized Phase III trial for Treatment of Muscle ...
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab ...
Flow diagram of the GETUG/AFU VESPER V05 trial for analyses of ...
Personalised chemotherapy based on tumour marker decline in poor ...
#getug2023 #getug | Unicancer
Summary of key aspects and results from the GETUG-AFU 15, CHAARTED and ...
(PDF) REPAIR_GETUG P16 - Relapse in previously irradiated Prostate bed ...
Emerging Systemic Treatment Strategies for High-Risk, Clinically ...
ESMO 2025: GETUG-AFU 43–PEACE8: Combination of Darolutamide and SBRT in ...
ASTRO 2024: Short-Term Androgen Deprivation Therapy and High-Dose ...
Impact of Divergent Differentiation and/or Histological Subtype of ...
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent ...
ESMO 2018: The Best of Munich 2018 Congress Genitourinary Tumors, Prostate
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to ...
Outcome According to Elective Pelvic Radiation Therapy in Patients With ...
Gastrointestinal metastases in renal cell carcinoma: A retrospective ...
APCCC 2024: In Patients Who Receive Salvage Radiation Therapy for BCR ...
GETUG-AFU 31: a phase I/II multicentre study evaluating the safety and ...
Very Long‐Term Complete Remission Can Be Achieved in Men With High‐Risk ...
Adrenal Metastases Are Associated with Poor Outcomes in Patients with ...
ESMO 2022: Pure or Mixed Basal/squamous Tumours Present Decreased ...
GETUG-AFU 18: Avaliação do escalonamento de dose da radioterapia no ...
Refining the Characterization and Outcome of Pathological Complete ...
The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in ...
Focus sur l’essai REPAIR_GETUG P16 - Réseau Pro Santé
Phase 3 GETUG-AFU-18 study: ADT boosts prostate cancer survival ...
Figure 1 from Salvage radiotherapy with or without short-term hormone ...
ASCO GU 2020: NIVOREN GETUG-AFU 26 Translational Study: Association of ...
Prostate carcinoma- clinical trial | PDF
(PDF) 791OUpdated results of GETUG-12, a phase III trial of docetaxel ...
(PDF) Randomized phase II trial in Prostate cancer with hormone ...
Urogenital Tumor Study Group (GETUG) - Unicancer
#jer2023 #getug | Unicancer
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in ...
Yesterday, I presented the @GETUG_Unicancer PEACE 2 trial at #ESTRO26 ...
ASCO GU 2022: Outcomes According to Histological Variants of Urothelial ...
#getug #icm #esmo25 #oncology #bladdercancer #nmibc #clinicalresearch # ...
Androgen-deprivation therapy alone or with docetaxel in non-castrate ...
Calendrier des événements COMM santé
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating ...
00111-X/asset/53e7e1cb-f4a2-47cb-8868-f69a47a34c2b/main.assets/gr2_lrg.jpg)
